Literature DB >> 12384930

The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis.

Mohammad J Al-Matar1, Ross E Petty, Lori B Tucker, Peter N Malleson, Maria-Louise Schroeder, David A Cabral.   

Abstract

OBJECTIVE: To evaluate features during the first 6 months of disease that may be associated with a poor outcome as measured principally by extension to a polyarticular disease course in patients with oligoarticular-onset juvenile rheumatoid arthritis (oligo-JRA).
METHODS: This study was a retrospective review of patients who fulfilled the American College of Rheumatology criteria for oligo-JRA, were followed up for at least 5 years, and did not have juvenile psoriatic arthritis, spondylarthropathy-like disease, or rheumatoid factor positivity. Data from the first 6 months of disease were collected. Continuous variables were dichotomized and then screened by univariate analysis for association with poor outcome at the last followup visit, as measured by extension of involvement (>4 accumulated involved joints) and by "clinically meaningful" extension (> or =10 accumulated joints). Variables significantly associated with this latter outcome, with the addition of disease duration as a confounding independent variable, were included in a multiple logistic regression analysis. The same variables were then examined in separate multiple logistic regression models to look at other measures of outcome, including use of disease-modifying antirheumatic drugs (DMARDs) at any time, erosive disease on radiographs, any remission of disease ever occurring, physician's global assessment of disease activity at the last visit, and disability as measured by the Childhood Health Assessment Questionnaire (C-HAQ)/HAQ.
RESULTS: Of the 205 patients (160 of whom were female) studied for a median of 10.8 years (range 5-26.6 years), 39.5% developed extension to >4 joints and 17.6% developed arthritis in > or =10 joints. Using the logistic regression model, symmetric disease was predictive of all measures of poor outcome: extension to > or =10 joints (odds ratio [OR] 19.2), the need to use DMARDs (OR 11.5), radiographic demonstration of erosive disease (OR 4.73), inflammatory activity at last followup visit (OR 3.23), no remission of disease (OR 4.73), and disability as measured by a C-HAQ score >0.12 (OR 2.95). Ankle and/or wrist disease was predictive of extension (OR 6.61) and erosions (OR 3.59). Wrist disease alone was predictive of the need to use DMARDs (OR 5.87) and of inflammatory disease activity at the last followup visit (OR 4.01). An elevated erythrocyte sedimentation rate (ESR) was predictive of extension (OR 3.76), the need to use DMARDs (OR 6.47), and no remission of disease (OR 2.30). Disease duration was a confounding variable for extension (OR 1.18) and erosive disease (OR 1.19).
CONCLUSION: The early presence of ankle and/or wrist disease, symmetric joint involvement, and an elevated ESR in a child with oligo-JRA indicates the likelihood of disease progression.

Entities:  

Mesh:

Year:  2002        PMID: 12384930     DOI: 10.1002/art.10544

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  26 in total

1.  Consider the wrist: a retrospective study on pediatric connective tissue disease with MRI.

Authors:  Charlotte M Nusman; J Merlijn van den Berg; Amara Nassar-Sheikh Rashid; Katerina Ntailiani; Apostolos Karantanas; Taco W Kuijpers; Mario Maas; Dieneke Schonenberg-Meinema
Journal:  Rheumatol Int       Date:  2019-06-20       Impact factor: 2.631

2.  Elevated IgG autoantibody production in oligoarticular juvenile idiopathic arthritis may predict a refractory course.

Authors:  M L Stoll; Q-Z Li; J Zhou; M Punaro; N J Olsen
Journal:  Clin Exp Rheumatol       Date:  2011-09-01       Impact factor: 4.473

3.  Remission rate is not dependent on the presence of antinuclear antibodies in juvenile idiopathic arthritis.

Authors:  M Glerup; T Herlin; M Twilt
Journal:  Clin Rheumatol       Date:  2017-01-17       Impact factor: 2.980

4.  Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment.

Authors:  Panayiota Nalbanti; Florentia Kanakoudi-Tsakalidou; Maria Trachana; Polyxeni Pratsidou-Gertsi; Evangelia Farmaki; Panagiotis Bamidis; Fotios Papachristou
Journal:  Rheumatol Int       Date:  2018-05-29       Impact factor: 2.631

5.  Clinical and associated inflammatory biomarker features predictive of short-term outcomes in non-systemic juvenile idiopathic arthritis.

Authors:  Elham Rezaei; Daniel Hogan; Brett Trost; Anthony J Kusalik; Gilles Boire; David A Cabral; Sarah Campillo; Gaëlle Chédeville; Anne-Laure Chetaille; Paul Dancey; Ciaran Duffy; Karen Watanabe Duffy; John Gordon; Jaime Guzman; Kristin Houghton; Adam M Huber; Roman Jurencak; Bianca Lang; Kimberly Morishita; Kiem G Oen; Ross E Petty; Suzanne E Ramsey; Rosie Scuccimarri; Lynn Spiegel; Elizabeth Stringer; Regina M Taylor-Gjevre; Shirley M L Tse; Lori B Tucker; Stuart E Turvey; Susan Tupper; Rae S M Yeung; Susanne Benseler; Janet Ellsworth; Chantal Guillet; Chandima Karananayake; Nazeem Muhajarine; Johannes Roth; Rayfel Schneider; Alan M Rosenberg
Journal:  Rheumatology (Oxford)       Date:  2020-09-01       Impact factor: 7.580

6.  Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience.

Authors:  Amieleena Chhabra; Cal Robinson; Kristin Houghton; David A Cabral; Kimberly Morishita; Lori B Tucker; Ross E Petty; Maggie Larché; Michelle Batthish; Jaime Guzman
Journal:  Rheumatology (Oxford)       Date:  2020-12-01       Impact factor: 7.580

7.  Frequency of joint involvement in juvenile idiopathic arthritis during a 5-year follow-up of newly diagnosed patients: implications for MR imaging as outcome measure.

Authors:  Robert Hemke; Charlotte M Nusman; Désirée M F M van der Heijde; Andrea S Doria; Taco W Kuijpers; Mario Maas; Marion A J van Rossum
Journal:  Rheumatol Int       Date:  2014-08-14       Impact factor: 2.631

8.  Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression.

Authors:  Patricia J Hunter; Kiran Nistala; Nipurna Jina; Ayad Eddaoudi; Wendy Thomson; Mike Hubank; Lucy R Wedderburn
Journal:  Arthritis Rheum       Date:  2010-03

Review 9.  [Juvenile idiopathic arthritis--clinical subgroups and classification].

Authors:  K Minden; M Niewerth
Journal:  Z Rheumatol       Date:  2008-03       Impact factor: 1.372

Review 10.  Current status of wrist imaging in juvenile idiopathic arthritis.

Authors:  Derk Frederik Matthaus Avenarius; Charlotte Nusman; Clara Malattia; Laura Tanturri de Horatio; Karen Rosendahl; Mario Maas; Lil-Sofie Ording Müller
Journal:  Pediatr Radiol       Date:  2018-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.